MEDSC — Medscope Holdings Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsMicro Cap
Annual cashflow statement for Medscope Holdings, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.71 | 3.34 | 5.63 | 5.76 | 2.95 |
| Depreciation | |||||
| Non-Cash Items | -1.54 | -2.38 | -2.94 | -2.98 | -0.974 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.158 | -2.04 | 14.1 | 1.62 | -10.2 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.39 | -1.01 | 16.8 | 4.46 | -8.2 |
| Capital Expenditures | -2.45 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -18.2 | -8.27 | -22 | -4.29 | 11.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -20.6 | -8.27 | -22 | -4.29 | 11.1 |
| Financing Cash Flow Items | — | — | — | 0.015 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 31.3 | -3.35 | 4.78 | 0.015 | -2.63 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12 | -12.6 | -0.394 | 0.184 | 0.31 |